Company Description
Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally.
Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay.
The company’s platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly.
It serves education, healthcare, travel, and business to business sectors. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016.
Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Country | United States |
Founded | 2009 |
IPO Date | May 26, 2021 |
Industry | Software - Infrastructure |
Sector | Technology |
Employees | 1,250 |
CEO | Michael Massaro |
Contact Details
Address: 141 Tremont Street, #10 Boston, Massachusetts 02111 United States | |
Phone | 617 329 4524 |
Website | flywire.com |
Stock Details
Ticker Symbol | FLYW |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $24.00 |
CIK Code | 0001580560 |
CUSIP Number | 302492103 |
ISIN Number | US3024921039 |
Employer ID | 27-0690799 |
SIC Code | 7389 |
Key Executives
Name | Position |
---|---|
Michael Massaro | Chief Executive Officer and Director |
Robert Orgel J.D. | President and Chief Operating Officer |
David R. King | Chief Technology Officer |
Peter Butterfield J.D. | General Counsel and Chief Compliance Officer |
Cosmin Pitigoi | Chief Financial Officer |
Barbara Cousins | CIO, CISO and Head of Internal Audit |
Allison MacLeod | Chief Marketing Officer |
Sharon Butler | Executive Vice President of Global Education |
John Talaga | Executive Vice President of Healthcare |
Ryan Frere | Executive Vice President and GM of B2B |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 22, 2025 | ARS | Filing |
Apr 22, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 22, 2025 | DEF 14A | Other definitive proxy statements |
Mar 10, 2025 | 144 | Filing |
Mar 6, 2025 | SCHEDULE 13G/A | Filing |
Mar 5, 2025 | SCHEDULE 13G/A | Filing |
Feb 26, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Feb 26, 2025 | 10-K | Annual Report |
Feb 25, 2025 | 8-K | Current Report |
Feb 11, 2025 | SCHEDULE 13G | Filing |